scispace - formally typeset
Journal ArticleDOI

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Palle Petersen, +4 more
- 28 Jan 1989 - 
- Vol. 333, Iss: 8631, pp 175-179
Reads0
Chats0
TLDR
The incidence of thromboembolic complications and vascular mortality were significantly lower in the warfarin group than in the aspirin and placebo groups, which did not differ significantly.
About
This article is published in The Lancet.The article was published on 1989-01-28. It has received 1636 citations till now. The article focuses on the topics: Warfarin & Stroke.

read more

Citations
More filters
Journal ArticleDOI

Short Deceleration Time of Mitral Inflow E Velocity: Prognostic Implication with Atrial Fibrillation Versus Sinus Rhythm☆☆☆★

TL;DR: Restrictive physiology as defined by Doppler echocardiography (deceleration time < or = 130 msec) appears to predict a similar poor prognosis with AF as with SR.
Journal ArticleDOI

Clinical trials update from the American Heart Association meeting: Omega-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE.

TL;DR: The American Heart Association meeting reported the results of several clinical trials of particular interest to those who care for patients with heart failure, including a role for ICDs in patients with non‐ischemic cardiomyopathy, although cost‐effectiveness remains in doubt.
Journal ArticleDOI

Low-dose amiodarone for atrial fibrillation: time for a prospective study?

TL;DR: The time has come for a large-scale prospective evaluation of low-dose amiodarone treatment early in the course of atrial fibrillation, which has a lower incidence of proarrhythmia and heart failure exacerbation compared with class I drugs and is well tolerated.
Journal ArticleDOI

Innovations in framework synthesis as a systematic review method

TL;DR: A spectrum of approaches to framework synthesis that are dependent on the extent to which theory is tentative, emergent, refined, or established are demonstrated; and that stakeholder involvement may help to understand the topic's complexity where theory is more nascent.
Journal ArticleDOI

Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit ligand.

TL;DR: Evidence is provided that AUTHR is associated with MC increase and redistribution and MGF overexpression and the role of redistributed MC and their mediators in the pathophysiology of atrial thrombosis requires further investigation.
References
More filters
Journal ArticleDOI

A multiple testing procedure for clinical trials.

TL;DR: The overall size of the procedure is shown to be controlled with virtually the same accuracy as the single sample chi-square test based on N(m1 + m2) observations and the power is found to bevirtually the same.
Journal ArticleDOI

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study

TL;DR: Controlled trials of anticoagulants or antiarrhythmic agents in persons with chronic AF may demonstrate if strokes can be prevented in this highly susceptible group.
Journal ArticleDOI

Explanatory and pragmatic attitudes in therapeutical trials

TL;DR: Most therapeutic trials are inadequately formulated from the earliest stages of their conception, and it often occurs that one type of approach is ethically less defensible than the other, or may even be ruled out altogether on ethical grounds.
Journal ArticleDOI

Randomised trial of prophylactic daily aspirin in British male doctors

TL;DR: A six year randomised trial was conducted among 5139 apparently healthy male doctors to see whether 500 mg aspirin daily would reduce the incidence of and mortality from stroke, myocardial infarction, or other vascular conditions.
Journal ArticleDOI

The natural history of lone atrial fibrillation. A population-based study over three decades.

TL;DR: It is concluded that lone atrial fibrillation in patients under the age of 60 at diagnosis is associated with a very low risk of stroke, and routine anticoagulation may not be warranted.
Related Papers (5)